跳至主要内容
临床试验/NCT02319720
NCT02319720终止1 期

A Randomized Study to Evaluate the Safety of Bone Marrow Aspirate Plus Cultured Bone Marrow Cells vs. Bone Marrow Aspirate Alone vs. Cultured Bone Marrow Cells Alone in the Treatment of Chronic Wounds.

Dr. E.Badiavas0 个研究点目标入组 11 人开始时间: 2008年7月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
终止
发起方
入组人数
11
主要终点
Safety Bone Marrow Fresh Cells directly to wounds (Number of adverse events)

研究概览

简要总结

Management of chronic wounds with:

  1. Bone Marrow Aspirate Plus Cultured Cells Group
  2. Cultured Cells Alone Group
  3. Bone Marrow Aspirate Alone Group
  4. Control Group

详细描述

Prior to randomization the subject will be screened for HIV, Hepatitis B and Hepatitis C. Women of child bearing age will be tested for pregnancy. As this is primarily a safety study, an electrocardiogram is done at the start of the study as a baseline in order to document any potential changes at a later date.

After the initial randomization visit the subject will return to have the wound examined once a week for 17 weeks after each treatment cycle begins or until the wound heals, whichever is earlier. Up to 4 treatment cycles will be allowed. As soon as the wound is completely healed, the subject will return once a month for 6 months to be certain the wound remains healed. The duration of the subject wound participation in the study is expected to be a maximum of 18 months following the start of study treatment.

The subjects in this study will be randomized into one of four arms. Three groups will receive bone marrow cells and one will not receive bone marrow cells (control group).

  1. Bone Marrow Aspirate (BMA) Plus Cultured Cells Group:

The subjects in this arm of the study will have fresh bone marrow aspirate administered to the wound at the time the bone marrow is taken. Part of the aspirate will be cultured. Once the cell cultures have matured (within 8 weeks) they will be checked for sterility, and frozen until applied to the wound. Up to three applications of cultured cells will be applied to the wound following the bone marrow biopsy. A single treatment cycle will consist of one application of a freshly obtained bone marrow aspirate and up to three applications of cultured cells derived from that aspirate. If the wound has not healed, up to three additional treatment cycles may be performed. Each bone marrow biopsy will be followed by direct application of fresh bone marrow to the wound and up to three applications of cultured cells (prepared from the most recent bone marrow biopsy). If the wound heals at any point during this protocol, no additional bone marrow biopsy procedures will be performed and no additional cells will be applied. 2. Cultured Cells Alone Group:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male or female subjects 18 years of age or older with chronic wounds
  • •Wound present for at least one year
  • •Subjects must understand and give written informed consent.
  • •Subjects must agree to have biopsies performed as per protocol
  • •Subjects must be accessible for weekly wound treatment and assessment visits
  • •Patients with chronic osteomyelitis will be eligible. They must however be afebrile, and have completed a 6-week course of intravenous and/or oral antibiotics. The use of chronic suppressive antibiotics will be allowed.

排除标准

  • •Have evidence of active infection at the wound site
  • •Evidence of active malignancy in ulcer
  • •Have any requirement for the use of systemic steroids or immunosuppressive agents
  • •Be a pregnant female or nursing mother
  • •Subjects who are known or found to be HIV positive
  • •Evidence of dry/wet gangrene
  • •History of alcohol or substance abuse within the past 18 months
  • •Patients with severe medical conditions
  • •Malignancy (other than non melanoma skin cancer) not in remission or in remission less than 5 years
  • •Life expectancy less than two years
  • •Severe cardiopulmonary disease restricting ambulation to the clinical facility
  • •Severe arterial or vascular disease requiring or best treated by amputation
  • •Untreated osteomyelitis affecting the ulcer area or osteomyelitis affecting the ulcer area not receiving aggressive treatment
  • •History of poor compliance, unreliability

研究组 & 干预措施

BMA/Cultured Bone Marrow Cells

Experimental

The subjects in this arm will have fresh bone marrow aspirate administered to the wound at the time the bone marrow is taken. Part of the aspirate will be cultured. Up to three applications of cultured cells will be applied to the wound following the bone marrow biopsy. A single treatment cycle will consist of one application of a freshly obtained bone marrow aspirate and up to three applications of cultured cells derived from that aspirate. If the wound has not healed, up to three additional treatment cycles may be performed. Each bone marrow biopsy will be followed by direct application of fresh bone marrow to the wound and up to three applications of cultured cells (prepared from the most recent bone marrow biopsy).

干预措施: Bone Marrow Aspirate (Biological)

BMA/Cultured Bone Marrow Cells

Experimental

The subjects in this arm will have fresh bone marrow aspirate administered to the wound at the time the bone marrow is taken. Part of the aspirate will be cultured. Up to three applications of cultured cells will be applied to the wound following the bone marrow biopsy. A single treatment cycle will consist of one application of a freshly obtained bone marrow aspirate and up to three applications of cultured cells derived from that aspirate. If the wound has not healed, up to three additional treatment cycles may be performed. Each bone marrow biopsy will be followed by direct application of fresh bone marrow to the wound and up to three applications of cultured cells (prepared from the most recent bone marrow biopsy).

干预措施: Cultured Bone Marrow Cells (Biological)

BMA/Cultured Bone Marrow Cells

Experimental

The subjects in this arm will have fresh bone marrow aspirate administered to the wound at the time the bone marrow is taken. Part of the aspirate will be cultured. Up to three applications of cultured cells will be applied to the wound following the bone marrow biopsy. A single treatment cycle will consist of one application of a freshly obtained bone marrow aspirate and up to three applications of cultured cells derived from that aspirate. If the wound has not healed, up to three additional treatment cycles may be performed. Each bone marrow biopsy will be followed by direct application of fresh bone marrow to the wound and up to three applications of cultured cells (prepared from the most recent bone marrow biopsy).

干预措施: Control (Procedure)

Cultured Bone Marrow Cells

Experimental

In this group, the bone marrow aspirate will be sent to the laboratory to be grown in tissue culture. Once the cell cultures have matured (within 8 weeks) they will be checked for sterility and frozen until applied to the subject's wound. Up to three applications of cultured cells will be applied to the wound following the bone marrow biopsy. A single treatment cycle will consist of up to three applications of cultured cells derived from a single bone marrow aspiration. If the wound has not healed, up to three additional treatment cycles may be performed. Each bone marrow biopsy will be followed by up to three applications of cultured cells (prepared from the most recent bone marrow biopsy).

干预措施: Cultured Bone Marrow Cells (Biological)

Cultured Bone Marrow Cells

Experimental

In this group, the bone marrow aspirate will be sent to the laboratory to be grown in tissue culture. Once the cell cultures have matured (within 8 weeks) they will be checked for sterility and frozen until applied to the subject's wound. Up to three applications of cultured cells will be applied to the wound following the bone marrow biopsy. A single treatment cycle will consist of up to three applications of cultured cells derived from a single bone marrow aspiration. If the wound has not healed, up to three additional treatment cycles may be performed. Each bone marrow biopsy will be followed by up to three applications of cultured cells (prepared from the most recent bone marrow biopsy).

干预措施: Control (Procedure)

Bone Marrow Aspirate

Experimental

The subjects in this group will have fresh bone marrow aspirate administered to the wound at the time the bone marrow is taken. A single treatment cycle will consist of one application of a freshly obtained bone marrow aspirate. If the wound has not healed, up to three additional bone marrow biopsies may be performed. If the wound heals at any point during this protocol, no additional bone marrow biopsy procedures will be performed and no additional cells will be applied.

干预措施: Bone Marrow Aspirate (Biological)

Bone Marrow Aspirate

Experimental

The subjects in this group will have fresh bone marrow aspirate administered to the wound at the time the bone marrow is taken. A single treatment cycle will consist of one application of a freshly obtained bone marrow aspirate. If the wound has not healed, up to three additional bone marrow biopsies may be performed. If the wound heals at any point during this protocol, no additional bone marrow biopsy procedures will be performed and no additional cells will be applied.

干预措施: Control (Procedure)

Control

Active Comparator

In this arm, subjects will receive currently approved treatments for their wound. These treatments will include debridement and dressing changes. Wound dressings allowed will include gauze, foam dressings, occlusive films, and non-stick pads. More advanced dressing materials such as Hydrocolloids, alginates, silver containing dressing and biomaterials can also be used. Compression will be utilized for lower extremity wounds.

干预措施: Control (Procedure)

结局指标

主要结局

Safety Bone Marrow Fresh Cells directly to wounds (Number of adverse events)

时间窗: 12 months

Number of adverse events reported

Safety Bone Marrow Cultured Cells directly to wounds (Number of adverse events)

时间窗: 12 months

Number of adverse events reported

Safety Bone Marrow Cultured Cells and Bone Marrow fresh cells directly to wounds (Number of adverse events)

时间窗: 12 months

Number of adverse events reported

次要结局

  • Efficacy Bone Marrow Fresh Cells in wounds (Healing rate)(12 months)
  • Efficacy Bone Marrow Cultured Cells in wounds (Healing rate)(12 months)
  • Efficacy Bone Marrow Cultured Cells and Bone Marrow Fresh Cells in wounds (Healing rate)(12 months)

研究者

发起方
Dr. E.Badiavas
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. E.Badiavas

Professor

University of Miami

相似试验